| | 40 | Participants: AK, JH, TD, WS, OE, JPas, GA, JM |
| | 41 | Apologies: KL, JPar |
| | 42 | |
| | 43 | * Publication |
| | 44 | * Overview |
| | 45 | * AK to move tables in post-accel into the overview. |
| | 46 | * End stations |
| | 47 | * AK read through section and made minor changes. |
| | 48 | * AK noted "in vitro" is in italics. JH to change to "in-vitro". |
| | 49 | * Infrastructure |
| | 50 | * AK to discuss costing with KL. |
| | 51 | * AK to see if there is space for the CAD image and floor plans. |
| | 52 | * Performance. |
| | 53 | * HTL: Will redo 127MeV protons and carbon dose rate simulations for the ion chamber. |
| | 54 | * AK to check numbers. |
| | 55 | * Pre-CDR |
| | 56 | * Deadline for comments is Thursday. |
| | 57 | * AOB |
| | 58 | * Capture R&D - TD |
| | 59 | * Will start plasma simulations to look at instabilities. |
| | 60 | * Look at injecting electrons into the plasma and will simulate this. |
| | 61 | * HTL: |
| | 62 | * Starting to think about more detailed simulations of Stage 1. |
